Posted By Jon Lavietes, Friday, November 20, 2020 Groundbreaking medical treatments come in many forms. The average person is likely to associate the pharmaceutical industry’s role in healing with prescription and over-the-counter drugs. While the pills, capsules, tablets, and liquids they... Continue Reading
Posted By Jon Lavietes, Friday, November 13, 2020 Mergers, acquisitions, and divestments is a different world from alliance management, yet these disciplines end up overlapping from time to time, so some alliance managers have gotten a taste of it in small doses. Should alliance managers dip their... Continue Reading
Posted By Jon Lavietes, Monday, October 19, 2020 Clinical trials have undergone a bit of a transformation in recent years. Much like what has happened with pharmaceutical manufacturing operations over the last decade and more, clinical trial site management is becoming less transactional and more... Continue Reading
Posted By Contributed by: Wissam “Will” Yafi, Founder & CEO – TIDWIT , Wednesday, October 7, 2020Updated: Tuesday, October 6, 2020 Last year I had a memorable lunch conversation with an alliance vice president of a very large tech GSI. “We have had an alliance... Continue Reading
Posted By Jon Lavietes, Monday, October 5, 2020 The ASAP biopharma community is no stranger to big pharma–biotech alliances and David-Goliath partnerships. In general, the story usually centers around an entity with an intriguing molecule accompanied by promising science looking for a... Continue Reading
Posted By Michael J. Burke, Monday, October 5, 2020 The road to digital health has been paved with good intentions: it’s about helping people take charge of their own health and wellness, after all. But it’s been a rocky road as well, and for pharma and tech companies taking the trip... Continue Reading
Posted By Jon Lavietes, Friday, September 25, 2020 Lou Gerstner once asked, 'Who says elephants can't dance?' For the past year and a half AstraZeneca and Daiichi Sankyo have been making their pachyderm sprint like a cheetah. Last week, at the 2020 ASAP BioPharma Conference, Jonathan Bell,... Continue Reading
Posted By Michael J. Burke, Friday, September 25, 2020 “It’s clear that over the last eight, nine months things have changed significantly. There really is no going back. The status quo is no more. Everything that has been done in the past can, and in many instances must, be... Continue Reading
“Humanity Is Relying on You!” Ed Cox Tells BioPharma Conference Attendees to Embrace the Challenge of Ending the Pandemic Posted By Jon Lavietes, Thursday, September 17, 2020 Ed Cox, executive vice president of strategic alliances and global head of digital medicine at EVERSANA, was... Continue Reading
Posted By Michael J. Burke, Thursday, September 17, 2020 Melinda Richter’s journey began very humbly, in a small wooden house with no running water in northern Canada. Growing up in that harsh environment with her parents and seven siblings wasn’t easy, especially in winter. But she... Continue Reading
Posted By Jon Lavietes, Wednesday, September 16, 2020 In the third and final session of the second day of the 2020 ASAP BioPharma Conference, medtech took center stage. Derek Danois, chief data officer at GE Healthcare, outlined his company’s nascent efforts to transform basic healthcare... Continue Reading
Posted By Michael J. Burke, Wednesday, September 16, 2020 There are many things biopharma alliance professionals do well, and many areas where they shine. Partnerships between life sciences companies and digital organizations, however, while on the rise, remain the new frontier for alliance... Continue Reading
